Author Correction: Immunoreactive peptide maps of SARS-CoV-2 and other human coronaviruses.
作者信息
Mishra Nischay, Huang Xi, Joshi Shreyas, Guo Cheng, Ng James, Thakkar Riddhi, Wu Yongjian, Dong Xin, Li Qianlin, Pinapati Richard S, Sullivan Eric, Caciula Adrian, Tokarz Rafal, Briese Thomas, Lu Jiahai, Lipkin W Ian
机构信息
Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA.
Sun Yat-sen University, Guangzhou, Guangdong Province, China.
出版信息
Commun Biol. 2021 Mar 9;4(1):339. doi: 10.1038/s42003-021-01866-z.
Abstract
摘要
相似文献
1
Author Correction: Immunoreactive peptide maps of SARS-CoV-2 and other human coronaviruses.
Commun Biol. 2021 Mar 9;4(1):339. doi: 10.1038/s42003-021-01866-z.
2
The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
Curr Pharm Des. 2020;26(41):5286-5292. doi: 10.2174/1381612826666200821120409.
3
[The genome comparison of SARS-CoV and other coronaviruses].
Yi Chuan. 2003 Jul;25(4):373-82.
4
G-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2.
Front Microbiol. 2020 Oct 23;11:567317. doi: 10.3389/fmicb.2020.567317. eCollection 2020.
5
Author Correction: Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia.
Nat Commun. 2021 Feb 25;12(1):1430. doi: 10.1038/s41467-021-21768-2.
6
Aerosol and surface persistence: Novel SARS-CoV-2 versus other coronaviruses.
J Infect Dev Ctries. 2020 Jul 31;14(7):748-749. doi: 10.3855/jidc.12887.
7
Peptide Nucleic Acid (PNA)-Enhanced Specificity of a Dual-Target Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) Assay for the Detection and Differentiation of SARS-CoV-2 from Related Viruses.
Diagnostics (Basel). 2020 Sep 30;10(10):775. doi: 10.3390/diagnostics10100775.
8
Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses.
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15193-15199. doi: 10.1073/pnas.2008176117. Epub 2020 Jun 10.
9
Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses.
bioRxiv. 2020 Apr 9:2020.04.05.026450. doi: 10.1101/2020.04.05.026450.
10
Author Correction: In vitro virucidal activity of Echinaforce, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Virol J. 2020 Nov 9;17(1):172. doi: 10.1186/s12985-020-01439-2.
引用本文的文献
1
IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes.
Cell Rep. 2022 May 31;39(9):110904. doi: 10.1016/j.celrep.2022.110904. Epub 2022 May 16.
2
ELISA-Based Analysis Reveals an Anti-SARS-CoV-2 Protein Immune Response Profile Associated with Disease Severity.
J Clin Med. 2022 Jan 14;11(2):405. doi: 10.3390/jcm11020405.
3
Temporal variations of country-specific mutational profile of SARS-CoV-2: effect on vaccine efficacy.
Future Virol. 2021 Oct;0(0). doi: 10.2217/fvl-2021-0062. Epub 2021 Nov 12.
Zotero 插件